Nurexone Biologic Inc (NRX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 1,320 | 920 | 716 | 1,164 | 1,060 |
| Operating Income | -1,320 | -920 | -716 | -1,164 | -1,060 |
| Interest Expense | 21 | N/A | N/A | N/A | N/A |
| Other Income | 16 | -2 | -21 | 6 | 20 |
| Pre-tax Income | -1,325 | -922 | -737 | -1,158 | -1,040 |
| Net Income Continuous | -1,325 | -922 | -737 | -1,158 | -1,040 |
| Net Income | $-1,325 | $-922 | $-737 | $-1,158 | $-1,040 |
| EPS Basic Total Ops | -0.02 | -0.02 | -0.02 | -0.03 | -0.02 |
| EPS Basic Continuous Ops | -0.02 | -0.02 | -0.02 | -0.03 | -0.02 |
| EPS Diluted Total Ops | -0.02 | -0.02 | -0.02 | -0.03 | -0.02 |
| EPS Diluted Continuous Ops | -0.02 | -0.02 | -0.02 | -0.03 | -0.02 |
| EBITDA(a) | $-1,291 | $-905 | $-692 | $-1,146 | $-1,054 |